Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.

Hadassah Medical Center

Status: Completed

Conditions: Pulpotomies Primary Teeth; Effectiveness of MedCem MTA® in Pulpotomies Primary Teeth

Treatments: Procedure: MedCem MTA pulpotomies in primary teeth.

Study type: Interventional

Funder types: Other

Identifiers

NCT01962077

Nathalie- HMO-CTIL

Details and patient eligibility

About

assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.

Enrollment: 60 patients

Sex: All

Ages: 2 to 10 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. healthy children
2. with Asymptomatic primary molars with a deep carious lesion;
3. Exposure of a vital pulp by caries;
4. No clinical or radiographic evidence of pulp degeneration, such as excessive bleeding from the root canal, internal root resorption, inter-radicular and/or periapical bone destruction,swelling, or sinus tract;
5. Ability to perform a leakage free restoration of the teeth using stainless steel crown, or amalgam/resin based restoration.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

MedCem MTA pulpotomies

Experimental group

Treatment:

Procedure: MedCem MTA pulpotomies in primary teeth.